USPTO serial 87167084
TRUSTED ANSWERS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 25, 2018
- Examiner
- RUTLAND, BARBARA A
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with TRUSTED ANSWERS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew Roppel
Andrew Roppel Holland & Hart LLPP.O. Box 8749Attn: Trademark DocketingDenver, CO 80201-8749Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use; solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in dna, rna and protein analysis; reagents for research purposes for scientific or medical research use; dna labeling reagents for research purposes; dna hybridization buffers, namely, reagents for research purposes for use in dna hybridization; dna cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting dna into phages; polymerase chain reaction or pcr related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, dna primers and dna vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use; lymphokines, namely, reagents for scientific and research use; cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, dna cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or pcr related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or lcr kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks in Class 001
- Similar marks named TRUSTED ANSWERS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 2, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 2, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 2, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 13, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 25, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 23, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 23, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 25, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 25, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 20, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 19, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 23, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 23, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 27, 2018 | IUAF | USE AMENDMENT FILED | — |
| Sep 27, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 6, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 4, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 4, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 4, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 5, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 3, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 3, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 3, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 11, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 25, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 3, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2016 | NWAP | NEW APPLICATION ENTERED | — |